Ilan Ganot - Jan 27, 2023 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ by David Tyrone Howton as attorney-in-fact for Ilan Ganot
Stock symbol
SLDB
Transactions as of
Jan 27, 2023
Transactions value $
-$11,407
Form type
4
Date filed
1/31/2023, 08:17 PM
Previous filing
Jan 5, 2023
Next filing
Mar 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Options Exercise +388 +34.31% 1.52K Jan 27, 2023 Wife F1, F2
transaction SLDB Common Stock Sale -$1.06K -141 -9.28% $7.49 1.38K Jan 27, 2023 Wife F3
transaction SLDB Common Stock Options Exercise +3.88K +4.73% 86K Jan 27, 2023 Direct F1, F4
transaction SLDB Common Stock Sale -$10.4K -1.38K -1.61% $7.49 84.6K Jan 27, 2023 Direct F3, F5
holding SLDB Common Stock 19.4K Jan 27, 2023 See Footnote F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Restricted Stock Units Options Exercise $0 -388 -24.98% $0.00 1.17K Jan 27, 2023 Common Stock 388 Wife F1, F7
transaction SLDB Restricted Stock Units Options Exercise $0 -3.88K -25% $0.00 11.7K Jan 27, 2023 Common Stock 3.88K Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Includes 1,462 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 30, 2022.
F3 This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
F4 Includes 490 shares of common stock and 1,462 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2022 and November 30, 2022, respectively.
F5 Represents 81,931 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
F6 Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
F7 On January 27, 2022 (the "Grant Date"), Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.
F8 On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.